Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatobiliary system, comprising the liver, gallbladder, and bile ducts, is evaluated through various diagnostic imaging modalities. These techniques assess the structure and function of these organs to diagnose diseases and guide treatment. Imaging modalities include nuclear medicine scans (HIDA scans), ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and MRCP. Radiotracers (e.g., 99mTc-IDA derivatives) are used in nuclear medicine to visualize bile flow. Contrast agents are used in CT and MRI to enhance anatomical detail. Imaging helps detect gallstones, tumors, abscesses, biliary obstruction, and assess liver function.
N/A (Diagnostic Imaging)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatobiliary System (Diagnostic Imaging) (N/A).